| scholarly article | Q13442814 |
| P50 | author | Christine E. Seidman | Q30123970 |
| Jonathan G Seidman | Q88295024 | ||
| Barry J Maron | Q113675641 | ||
| P2093 | author name string | William J McKenna | |
| Kristen K Patton | |||
| Hideshi Niimura | |||
| Johann Soults | |||
| P2860 | cites work | Myosin heavy chain gene expression in human heart failure | Q24561412 |
| Molecular basis of cardiac performance. Plasticity of the myocardium generated through protein isoform switches | Q24621025 | ||
| Three-dimensional structure of myosin subfragment-1: a molecular motor | Q27731679 | ||
| Mutations in the genes for cardiac troponin T and alpha-tropomyosin in hypertrophic cardiomyopathy | Q28236892 | ||
| Mutations in the gene for cardiac myosin-binding protein C and late-onset familial hypertrophic cardiomyopathy | Q28268916 | ||
| Molecular diversity of myofibrillar proteins: gene regulation and functional significance | Q28277318 | ||
| Natural history of hypertrophic cardiomyopathy in the elderly | Q33160724 | ||
| Prognosis in hypertrophic cardiomyopathy: role of age and clinical, electrocardiographic and hemodynamic features | Q33173218 | ||
| Hypertrophic cardiomyopathy in the elderly | Q33610816 | ||
| Asymmetrical hypertrophy of the heart in young adults | Q39319375 | ||
| Hypertrophic cardiomyopathy. Interrelations of clinical manifestations, pathophysiology, and therapy (1). | Q39759066 | ||
| Characteristics and prognostic implications of myosin missense mutations in familial hypertrophic cardiomyopathy | Q44319774 | ||
| Idiopathic Hypertrophic Subaortic Stenosis as Observed in a Large Community Hospital: Relation to Age and History of Hypertension | Q44543520 | ||
| Hypertrophic cardiomyopathy in the aged | Q45001866 | ||
| Patterns of inheritance in hypertrophic cardiomyopathy: assessment by M-mode and two-dimensional echocardiography. | Q52694899 | ||
| Spectrum of clinical phenotypes and gene variants in cardiac myosin-binding protein C mutation carriers with hypertrophic cardiomyopathy. | Q52962652 | ||
| Familial Prevalence and Genetic Transmission of Idiopathic Hypertrophic Subaortic Stenosis | Q69582981 | ||
| Elderly patients with hypertrophic cardiomyopathy: a subset with distinctive left ventricular morphology and progressive clinical course late in life | Q69934670 | ||
| Hypertensive hypertrophic cardiomyopathy or hypertrophic cardiomyopathy with hypertension? A study of 78 patients | Q69948975 | ||
| Idiopathic Hypertrophic Subaortic Stenosis in the Elderly | Q70560858 | ||
| Hypertrophic subaortic stenosis in the aged | Q72331685 | ||
| Hypertrophic cardiomyopathy | Q73522948 | ||
| P433 | issue | 4 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | hypertrophic cardiomyopathy | Q1364270 |
| ventricular cardiac muscle tissue morphogenesis | Q14852037 | ||
| Troponin I3, cardiac type | Q21108986 | ||
| Myosin heavy chain 6 | Q21119515 | ||
| Myosin binding protein C3 | Q21120896 | ||
| P304 | page(s) | 446-51 | |
| P577 | publication date | 2002-01-29 | |
| P1433 | published in | Circulation | Q578091 |
| P1476 | title | Sarcomere protein gene mutations in hypertrophic cardiomyopathy of the elderly | |
| P478 | volume | 105 |
| Q39161689 | A Combined Linkage and Exome Sequencing Analysis for Electrocardiogram Parameters in the Erasmus Rucphen Family Study |
| Q37209940 | A Next-Generation Sequencing Approach to Identify Gene Mutations in Early- and Late-Onset Hypertrophic Cardiomyopathy Patients of an Italian Cohort. |
| Q64070579 | A case report of recessive restrictive cardiomyopathy caused by a novel mutation in cardiac troponin I (TNNI3) |
| Q24645034 | A common MYBPC3 (cardiac myosin binding protein C) variant associated with cardiomyopathies in South Asia |
| Q42173357 | A novel Myosin essential light chain mutation causes hypertrophic cardiomyopathy with late onset and low expressivity |
| Q33379935 | Adverse events in families with hypertrophic or dilated cardiomyopathy and mutations in the MYBPC3 gene |
| Q34275552 | American College of Cardiology/European Society of Cardiology clinical expert consensus document on hypertrophic cardiomyopathy. A report of the American College of Cardiology Foundation Task Force on Clinical Expert Consensus Documents and the Euro |
| Q42174834 | Amino Acid Changes at Arginine 204 of Troponin I Result in Increased Calcium Sensitivity of Force Development |
| Q34018918 | Association of 25 bp deletion in MYBPC3 gene with left ventricle dysfunction in coronary artery disease patients |
| Q64057343 | CMR derived left ventricular septal convexity in carriers of the hypertrophic cardiomyopathy-causing MYBPC3-Q1061X mutation |
| Q21134934 | Cardiac alpha-myosin (MYH6) is the predominant sarcomeric disease gene for familial atrial septal defects |
| Q34980505 | Cardiac troponin I Pro82Ser variant induces diastolic dysfunction, blunts β-adrenergic response, and impairs myofilament cooperativity |
| Q38724869 | Cardiac troponin structure-function and the influence of hypertrophic cardiomyopathy associated mutations on modulation of contractility |
| Q90435028 | Cardiomyopathies |
| Q21284968 | Cardiomyopathy classification: ongoing debate in the genomics era |
| Q39711263 | Cardiovascular magnetic resonance of mitral valve length in hypertrophic cardiomyopathy |
| Q27324640 | Chamber Specific Gene Expression Landscape of the Zebrafish Heart |
| Q53812028 | Characterization of Left Atrial Mechanics in Hypertrophic Cardiomyopathy and Essential Hypertension Using Vector Velocity Imaging. |
| Q52954578 | Clinical course of hypertrophic cardiomyopathy with survival to advanced age. |
| Q48177445 | Clinical outcomes associated with sarcomere mutations in hypertrophic cardiomyopathy: a meta-analysis on 7675 individuals |
| Q34263302 | Comparative echocardiographic and clinical features of hypertrophic cardiomyopathy in 5 breeds of cats: a retrospective analysis of 344 cases (2001-2011). |
| Q51899104 | Comparative transcriptomics implicates mechanisms of evolved pollution tolerance in a killifish population |
| Q37227838 | Contemporary treatment of hypertrophic cardiomyopathy |
| Q38816583 | Contribution of Post-translational Phosphorylation to Sarcomere-Linked Cardiomyopathy Phenotypes. |
| Q46564299 | Contribution of rare inherited and de novo variants in 2,871 congenital heart disease probands. |
| Q57455691 | Depressed cardiac myofilament function in human diabetes mellitus |
| Q39729064 | Diagnostic disparity and identification of two TNNI3 gene mutations, one novel and one arising de novo, in South African patients with restrictive cardiomyopathy and focal ventricular hypertrophy. |
| Q35070184 | Diltiazem treatment for pre-clinical hypertrophic cardiomyopathy sarcomere mutation carriers: a pilot randomized trial to modify disease expression |
| Q36303049 | Dissociation of structural and functional phenotypes in cardiac myosin-binding protein C conditional knockout mice |
| Q33763883 | Echocardiography in patients with hypertrophic cardiomyopathy: usefulness of old and new techniques in the diagnosis and pathophysiological assessment |
| Q37211593 | Effects of Cardiac Troponin I Mutation P83S on Contractile Properties and the Modulation by PKA-Mediated Phosphorylation |
| Q85337912 | Electrocardiographic changes announcing the rapid development of apical hypertrophic cardiomyopathy in an adult male |
| Q58728912 | Emergence of Members of TRAF and DUB of Ubiquitin Proteasome System in the Regulation of Hypertrophic Cardiomyopathy |
| Q37255253 | Evolving molecular diagnostics for familial cardiomyopathies: at the heart of it all |
| Q54491858 | Exome analysis of a family with Wolff-Parkinson-White syndrome identifies a novel disease locus. |
| Q33997765 | Experimental therapies in hypertrophic cardiomyopathy |
| Q30366945 | Familial hypertrophic cardiomyopathy associated with cardiac beta-myosin heavy chain and troponin I mutations. |
| Q44448940 | Familial hypertrophic cardiomyopathy mutations in troponin I (K183D, G203S, K206Q) enhance filament sliding |
| Q35623368 | Familial hypertrophic cardiomyopathy: clinical features, molecular genetics and molecular genetic testing |
| Q35812684 | Familial screening and genetic counselling in hypertrophic cardiomyopathy: the Rotterdam experience |
| Q41989876 | Formation, contraction, and mechanotransduction of myofribrils in cardiac development: clues from genetics |
| Q27334821 | Functional modulation of cardiac form through regionally confined cell shape changes |
| Q26316693 | Genetic Misdiagnoses and the Potential for Health Disparities |
| Q36960609 | Genetic basis of hypertrophic cardiomyopathy: from bench to the clinics |
| Q38125765 | Genetic biomarkers in hypertrophic cardiomyopathy. |
| Q36712985 | Genetic complexity in hypertrophic cardiomyopathy revealed by high-throughput sequencing |
| Q38118161 | Genetic etiology and evaluation of sudden cardiac death |
| Q34999606 | Genetics and clinical destiny: improving care in hypertrophic cardiomyopathy |
| Q28248327 | Genetics of hypertrophic cardiomyopathy in eastern Finland: few founder mutations with benign or intermediary phenotypes |
| Q38261314 | Genetics of hypertrophic cardiomyopathy: advances and pitfalls in molecular diagnosis and therapy |
| Q34203505 | Genetics of sudden cardiac death |
| Q24624928 | Genome-wide association analysis identifies multiple loci related to resting heart rate |
| Q42962415 | Genomic Insights into Cardiomyopathies: A Comparative Cross-Species Review |
| Q38041426 | Heavy and light roles: myosin in the morphogenesis of the heart |
| Q34372769 | High prevalence of Arginine to Glutamine substitution at 98, 141 and 162 positions in Troponin I (TNNI3) associated with hypertrophic cardiomyopathy among Indians |
| Q48179814 | Hypertrophic Cardiomyopathy Genotype Prediction Models in a Pediatric Population. |
| Q92327209 | Hypertrophic Cardiomyopathy: An Overview of Genetics and Management |
| Q42515078 | Hypertrophic Cardiomyopathy: Genetics, Pathogenesis, Clinical Manifestations, Diagnosis, and Therapy |
| Q61897156 | Hypertrophic cardiomyopathy |
| Q80172333 | Hypertrophic cardiomyopathy |
| Q37603719 | Hypertrophic cardiomyopathy in 2013: Current speculations and future perspectives |
| Q35087752 | Hypertrophic cardiomyopathy: from gene defect to clinical disease |
| Q33992358 | Hypertrophic cardiomyopathy: from genetics to treatment |
| Q38203157 | Hypertrophic cardiomyopathy: how do mutations lead to disease? |
| Q37070209 | Hypertrophic cardiomyopathy: the genetic determinants of clinical disease expression |
| Q34772983 | Identifying sarcomere gene mutations in hypertrophic cardiomyopathy: a personal history |
| Q36371337 | Impact of Mendelian inheritance in cardiovascular disease |
| Q57314990 | Knock-out of nexilin in mice leads to dilated cardiomyopathy and endomyocardial fibroelastosis |
| Q45387084 | Knockdown of alpha myosin heavy chain disrupts the cytoskeleton and leads to multiple defects during chick cardiogenesis |
| Q35176657 | Knockdown of embryonic myosin heavy chain reveals an essential role in the morphology and function of the developing heart |
| Q34248530 | Late onset sporadic dilated cardiomyopathy caused by a cardiac troponin T mutation |
| Q84577781 | Long-term outcome of 4 Korean families with hypertrophic cardiomyopathy caused by 4 different mutations |
| Q97530128 | Mapping signalling perturbations in myocardial fibrosis via the integrative phosphoproteomic profiling of tissue from diverse sources |
| Q37866169 | Mechanotransduction: the role of mechanical stress, myocyte shape, and cytoskeletal architecture on cardiac function |
| Q37675919 | Molecular basis of hereditary cardiomyopathy: abnormalities in calcium sensitivity, stretch response, stress response and beyond |
| Q36344118 | Molecular genetics in hypertrophic cardiomyopathy: towards individualized management of the disease |
| Q24296801 | Mutation in myosin heavy chain 6 causes atrial septal defect |
| Q73296884 | Mutation of the phospholamban promoter associated with hypertrophic cardiomyopathy |
| Q57315175 | Mutation spectrum in a large cohort of unrelated consecutive patients with hypertrophic cardiomyopathy |
| Q28264798 | Mutations in Troponin that cause HCM, DCM AND RCM: what can we learn about thin filament function? |
| Q37314360 | Mutations in the cardiac troponin T gene show various prognoses in Japanese patients with hypertrophic cardiomyopathy |
| Q35581582 | Mutations of the beta myosin heavy chain gene in hypertrophic cardiomyopathy: critical functional sites determine prognosis |
| Q34629550 | Myocardial fibrosis as an early manifestation of hypertrophic cardiomyopathy |
| Q57623036 | Myocardial perfusion, oxidative metabolism, and free fatty acid uptake in patients with hypertrophic cardiomyopathy attributable to the Asp175Asn mutation in the α-tropomyosin gene: A positron emission tomography study |
| Q35759293 | Myosin binding protein C: structural abnormalities in familial hypertrophic cardiomyopathy |
| Q33647442 | Myosin-binding Protein C Compound Heterozygous Variant Effect on the Phenotypic Expression of Hypertrophic Cardiomyopathy |
| Q34474908 | Narrative review: harnessing molecular genetics for the diagnosis and management of hypertrophic cardiomyopathy |
| Q42623343 | On mice, rabbits, and human heart failure |
| Q30424149 | Prediction of protein-destabilizing polymorphisms by manual curation with protein structure |
| Q52803438 | Prevalence of clinically apparent hypertrophic cardiomyopathy in Germany-An analysis of over 5 million patients. |
| Q99413479 | Progressive Proteome Changes in the Myocardium of a Pig Model for Duchenne Muscular Dystrophy |
| Q89804842 | RNA Splicing Defects in Hypertrophic Cardiomyopathy: Implications for Diagnosis and Therapy |
| Q40239041 | Reduction of left ventricular longitudinal global and segmental systolic functions in patients with hypertrophic cardiomyopathy: Study of two-dimensional tissue motion annular displacement |
| Q92669049 | Retrospective analysis of clinical phenotype and prognosis of hypertrophic cardiomyopathy complicated with hypertension |
| Q39650084 | Role of common sarcomeric gene polymorphisms in genetic susceptibility to left ventricular dysfunction |
| Q34626686 | Sarcomere gene mutations in hypertrophy and heart failure |
| Q36369925 | Sarcomeric proteins and familial hypertrophic cardiomyopathy: linking mutations in structural proteins to complex cardiovascular phenotypes |
| Q90016976 | Screening of MYH7 gene mutation sites in hypertrophic cardiomyopathy and its significance |
| Q28276100 | Shared genetic causes of cardiac hypertrophy in children and adults |
| Q47642830 | Slowed atrial and atrioventricular conduction and depressed HRV in a murine model of hypertrophic cardiomyopathy |
| Q36739221 | Structural and kinetic effects of hypertrophic cardiomyopathy related mutations R146G/Q and R163W on the regulatory switching activity of rat cardiac troponin I |
| Q42552367 | Structure and interactions of myosin-binding protein C domain C0: cardiac-specific regulation of myosin at its neck? |
| Q37957391 | Systolic heart failure in South Asians |
| Q35829323 | Targeted Next-Generation Sequencing Reveals Hot Spots and Doubly Heterozygous Mutations in Chinese Patients with Familial Cardiomyopathy |
| Q33653498 | The Genetic Challenges and Opportunities in Advanced Heart Failure |
| Q37515701 | The Ku protein complex interacts with YY1, is up-regulated in human heart failure, and represses alpha myosin heavy-chain gene expression. |
| Q37766174 | The many faces of hypertrophic cardiomyopathy: from developmental biology to clinical practice |
| Q35771667 | The pathology of hypertrophic cardiomyopathy |
| Q34327150 | The role of sarcomere gene mutations in patients with idiopathic dilated cardiomyopathy |
| Q64232857 | Three perspectives on the molecular basis of hypercontractility caused by hypertrophic cardiomyopathy mutations |
| Q48157224 | Three-dimensional echocardiography for the assessment of left ventricular geometry and papillary muscle morphology in hypertrophic cardiomyopathy. |
| Q33683749 | Toward transcriptional therapies for the failing heart: chemical screens to modulate genes |
| Q44403968 | Two novel mutations in the beta-myosin heavy chain gene associated with dilated cardiomyopathy |
| Q34425285 | Two novel mutations of the MYBPC3 gene identified in Chinese families with hypertrophic cardiomyopathy |
| Q35590181 | Unexpectedly low mutation rates in beta-myosin heavy chain and cardiac myosin binding protein genes in Italian patients with hypertrophic cardiomyopathy. |
| Q48020405 | Variable clinical manifestation of a novel missense mutation in the alpha-tropomyosin (TPM1) gene in familial hypertrophic cardiomyopathy |
| Q47877602 | Yield of genetic testing in hypertrophic cardiomyopathy |
| Q80221244 | [Hypertrophic myocardiopathy: how to predict its evolution?] |
| Q28288720 | α-cardiac myosin heavy chain (MYH6) mutations affecting myofibril formation are associated with congenital heart defects |
Search more.